CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism

Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 engineering of the CYP3A5 *3 locus (rs776746) in human liver cell line HuH-7 (CYP3A5 *3/*3) has led to three CYP3A5 *1 cell lines by deletion of the exon 3B splice junction or point mutation. Cell lines CYP3A5 *1/*3 sd (single d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drug Metab Dispos
Main Authors: Dorr, Casey R., Remmel, Rory P., Muthusamy, Amutha, Fisher, James, Moriarity, Branden S., Yasuda, Kazuto, Wu, Baolin, Guan, Weihua, Schuetz, Erin G., Oetting, William S., Jacobson, Pamala A., Israni, Ajay K.
Formato: Artigo
Idioma:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2017
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518718/
https://ncbi.nlm.nih.gov/pubmed/28533324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.117.076307
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares